IR (Infrared) fluctuates 118.0% in 24 hours: High trading volume drives sharp price swings
Bitget Pulse2026/05/07 22:02Volatility Brief
In the past 24 hours, IR's price rebounded from a low of $0.01595 to a high of $0.03477, and is currently at $0.018, with a fluctuation amplitude of 118.0%. Trading volume surged significantly, with a 24-hour turnover around $3.86–3.92 million and a market cap of about $3.8 million, indicating high activity under relatively low liquidity.
Brief Analysis of the Abnormal Movement
• No IR official announcements, major news events, or significant on-chain data (such as large whale transfers) have been detected in the past 24 hours.
• Trading volume was higher than usual (around $3–4 million), which may be the main factor directly amplifying price volatility. Such low market cap tokens are commonly traded speculatively on DEX.
Market View and Outlook
There has been limited discussion on Platform X and in the community, with no mainstream sentiment hype or analyst forecasts; some data platforms show a minor short-term rebound, but low liquidity tokens are prone to sell-off pressure. It is advised to watch changes in trading volume and potential rug risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for information reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
Crypto prices
More
